Terms: = Liver cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB
389 results:
1. Genetic Analyses of Primary liver cancer Cell Lines: Correspondence With Morphological Features of Original Tumors.
Akiba J; Ogasawara S; Yano H
Cancer Genomics Proteomics; 2024; 21(3):260-271. PubMed ID: 38670592
[TBL] [Abstract] [Full Text] [Related]
2. Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing.
Zheng L; Wang Y; Liu Z; Wang Z; Tao C; Wu A; Li H; Xiao T; Li Z; Rong W
Cancer Med; 2024 Apr; 13(7):e7043. PubMed ID: 38572921
[TBL] [Abstract] [Full Text] [Related]
3. [Multi-omics combined test performance effectiveness on opportunistic screening of high-risk liver cancer population].
Xie C; Lin BL; Deng H; Zhang XH; Zhao QY; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):140-147. PubMed ID: 38514263
[No Abstract] [Full Text] [Related]
4. Analysis of Tumor-Associated AXIN1 Missense Mutations Identifies Variants That Activate β-Catenin Signaling.
Zhang R; Li S; Schippers K; Li Y; Eimers B; Lavrijsen M; Wang L; Cui G; Chen X; Peppelenbosch MP; Lebbink JHG; Smits R
Cancer Res; 2024 May; 84(9):1443-1459. PubMed ID: 38359148
[TBL] [Abstract] [Full Text] [Related]
5. DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis.
Sanceau J; Poupel L; Joubel C; Lagoutte I; Caruso S; Pinto S; Desbois-Mouthon C; Godard C; Hamimi A; Montmory E; Dulary C; Chantalat S; Roehrig A; Muret K; Saint-Pierre B; Deleuze JF; Mouillet-Richard S; Forné T; Grosset CF; Zucman-Rossi J; Colnot S; Gougelet A
Mol Ther; 2024 Apr; 32(4):1125-1143. PubMed ID: 38311851
[TBL] [Abstract] [Full Text] [Related]
6. Hyperactivation of β-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis.
Wang K; Wu J; Yang Z; Zheng B; Shen S; Wang RR; Zhang Y; Wang HY; Chen L; Qiu X
Cancer Lett; 2024 Apr; 586():216690. PubMed ID: 38307410
[TBL] [Abstract] [Full Text] [Related]
7. FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis.
Ursic-Bedoya J; Desandré G; Chavey C; Marie P; Polizzi A; Rivière B; Guillou H; Assenat E; Hibner U; Gregoire D
EMBO Mol Med; 2024 Feb; 16(2):238-250. PubMed ID: 38228803
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic and predictive biomarkers in paediatric solid tumours.
Glembocki AI; Somers GR
Pathology; 2024 Mar; 56(2):283-296. PubMed ID: 38216399
[TBL] [Abstract] [Full Text] [Related]
9. Establishment and characterization of a highly metastatic hepatocellular carcinoma cell line.
Huang J; Sun M; Wang M; Yu A; Zheng H; Bu C; Zhou J; Zhang Y; Qiao Y; Hu Z
Bioengineered; 2024 Dec; 15(1):2296775. PubMed ID: 38184822
[TBL] [Abstract] [Full Text] [Related]
10. Protocol for generation of humanized HCC mouse model and cancer-driver mutations using CRISPR-Cas9.
Zhu Y; Tahara SM; Tsukamoto H; Machida K
STAR Protoc; 2023 Dec; 4(4):102389. PubMed ID: 38103196
[TBL] [Abstract] [Full Text] [Related]
11. Genomic and immune landscape in hepatocellular carcinoma: Implications for personalized therapeutics.
Zheng J; Chen J; Wang S; Yang D; Zhou P
Environ Toxicol; 2024 Mar; 39(3):1601-1616. PubMed ID: 38009667
[TBL] [Abstract] [Full Text] [Related]
12. Comparative Clinicopathologic and Genomic Analysis of Hepatocellular Neoplasm, Not Otherwise Specified, and Hepatoblastoma.
Zhou S; Sarabia SF; Estrine D; Ostrow D; Schmidt RJ; Warren M; Raca G; Shillingford N; Wang L; Pawel B; Stein JE; Biegel JA; Lopez-Terrada D; Mascarenhas L; Ji J
Mod Pathol; 2024 Feb; 37(2):100385. PubMed ID: 37992967
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic hub gene CBX2 drives a cancer stem cell-like phenotype in HCC revealed by multi-omics and multi-cohorts.
Meng Q; Zhou Q; Chen X; Chen J
Aging (Albany NY); 2023 Nov; 15(22):12817-12851. PubMed ID: 37980163
[TBL] [Abstract] [Full Text] [Related]
14. Whole-genome sequencing and RNA sequencing analysis reveals novel risk genes and differential expression patterns in hepatoblastoma.
Wang W; Zhang N; Chen L; Zhao X; Shan Y; Yang F; Wang B; Gao H; Xu M; Tang P; Qin S; Gu S
Gene; 2024 Mar; 897():147991. PubMed ID: 37972697
[TBL] [Abstract] [Full Text] [Related]
15. Hepatocellular Carcinomas with Concomitant Mutations of TERT, TP53, and ctnnb1: Is There a Role for Artificial Intelligence?
Chillotti S; Maloberti T; Degiovanni A; Malvi D; D'Errico A; de Biase D; Vasuri F
Crit Rev Oncog; 2023; 28(3):31-35. PubMed ID: 37968991
[TBL] [Abstract] [Full Text] [Related]
16. Molecular Profiling of a Hepatocellular Neoplasm Not Otherwise Specified (HCN-NOS) Demonstrates Distinct Molecular Features in Hepatoblastoma and HCC-Like Components.
Chen Wongworawat Y; Sarabia SF; Urbicain M; Francalanci P; Sumazin P; Alaggio R; López-Terrada DH
Pediatr Dev Pathol; 2024; 27(2):169-175. PubMed ID: 37903123
[TBL] [Abstract] [Full Text] [Related]
17. Tumor biology, immune infiltration and liver function define seven hepatocellular carcinoma subtypes linked to distinct drivers, survival and drug response.
Wu R; Gao Y; Zhao X; Guo S; Zhou H; Zhang Y; Hou Y; Mei L; Zhi H; Wang P; Li X; Ning S; Zhang Y
Comput Biol Med; 2023 Dec; 167():107593. PubMed ID: 37883849
[TBL] [Abstract] [Full Text] [Related]
18. Impact of Cell-Debris and Room-Temperature Storage on Urine Circulating Tumor DNA from Hepatocellular Carcinoma.
Kim AK; Lin SY; Wang Z; Luu H; Hamilton JP; Song W; Su YH
J Mol Diagn; 2023 Dec; 25(12):913-920. PubMed ID: 37813297
[TBL] [Abstract] [Full Text] [Related]
19. Focal nodular hyperplasia-like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation.
Umetsu SE; Joseph NM; Cho SJ; Morotti R; Deshpande V; Jain D; Kakar S
Hum Pathol; 2023 Dec; 142():20-26. PubMed ID: 37806391
[TBL] [Abstract] [Full Text] [Related]
20. Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma.
Cowzer D; White JB; Chou JF; Chen PJ; Kim TH; Khalil DN; El Dika IH; Columna K; Yaqubie A; Light JS; Shia J; Yarmohammadi H; Erinjeri JP; Wei AC; Jarnagin W; Do RKG; Solit DB; Capanu M; Shah RH; Berger MF; Abou-Alfa GK; Harding JJ
JCO Precis Oncol; 2023 Sep; 7():e2300272. PubMed ID: 37769223
[TBL] [Abstract] [Full Text] [Related]
[Next]